Farzan electronic newsletter is the first of its kind to address research in Iran. It is sent on a monthly basis for medical researchers in Iran and abroad. The first newsletter was published in January 2006 in 800 copies. After 6 years, the newsletter is currently being circulated in 70,000 copies.

The diverse sections of the newsletter include interviews with experts of medical sciences, analytical papers, educational articles, and research news of the last month. The diversity of content has attracted a wide spectrum of individuals involved with medical sciences. Another strong feature of this electronic monthly newsletter is its regular and punctual delivery over the last 6 years.

Farzan News: Farzan Institute selected as the top entrepreneur and awarded the golden beam award for entrepreneurship by EMIC Tech

Farzan Institute for Science, Research and Technology was selected as the top entrepreneur in the field of information and communications technology in the first national congress of Entrepreneurship Management in Information and Communications Technology (EMIC Tech 2012). In this congress, Dr. Gholamreza Habibi, CEO of the Farzan Institute, was awarded the Golden Beam statuette of entrepreneurship.

In the first national congress of entrepreneurship in information and communications technology, Farzan Institute was chosen the top entrepreneur corporation in the section of technology parks and growth centers, and was thereby awarded the golden beam award. Dr. Gholamreza Habibi, CEO of the institute, represented Farzan in the congress.
The first national congress of entrepreneurship in information and communications technology was held on November 6 and 7 in Esteghlal Hotel, Tehran with the purpose of discussing strategies for producing products and services in the field of information and communications technology (ICT). During the two days of the congress, an exposition of information and communications technology was held simultaneously.

This congress, the first national congress on entrepreneurship management in information and communications technology (EMIC Tech 2012) was held with the purpose of discussing strategies for producing products and services in the field of information and communications technology as well as providing solutions for improving the spirit of entrepreneurship.

In the first national congress of entrepreneurship management in information and communications technology, in addition to Farzan Institute, other personalities, corporations and organizations were appreciated in categories of top entrepreneur of the year, top female entrepreneur of the year, entrepreneur manager, young entrepreneur, top entrepreneur corporation, top entrepreneur exporter, top entrepreneur organization, entrepreneur internet site, top entrepreneurship researcher, top entrepreneur bank, top entrepreneur project, top entrepreneur in the field of information technology, top entrepreneur in the field of electronic banking, and top media supporting entrepreneurship.

The congress was sponsored by the presidential office for development of management and human resources, IT watchdog institute, organization of information technology, Iranian computer guild, science and technology park of Zanjan school of graduate studies, Iran microelctronic research center, and Mellat bank.

Awarding the Medal of Supporting National Production to CEO of Farzan Institute in the Festival of Iranian Products

In the year labeled National Production and Support of Iranian Labor and Capital, the products of the institute in the domain of information technology (especially Faradata clinical Data Management Platform and Farasa – system of electronic education and evaluation) were presented in the festival of Iranian product and Dr. Gholamreza Habibi was acknowledged as the top national entrepreneur and CEO of Farzan Institute for Science, Research and Technology and awarded the medal of supporting national product.

“Festival of Iranian product: Universal technology and standards” was held to appreciate the companies and corporations active in producing Iranian products. A medal of supporting national product with a certificate of honors was awarded to the selected individuals in the festival. The festival of Iranian product was held in October 2012 in the conference hall of the Islamic Republic of Iran Broadcasting corporation.

A review of the institute’s background was published in the booklet of the conference. The report introduced the products and services of the institute, its rank as top entrepreneur of Tehran province as well the top national entrepreneur, the top entrepreneur selected by the university of economical studies in 2011, and reception of the statuette of innovation in the national conference of innovation pioneers, and selection by the national conference of corporations in 2012.

Part of the report deals with the institute’s products in the field of information technology. The products include Farasa software (system of electronic education and evaluation), Faradata software (system for management of clinical data for clinical pharmaceutical studies), Faranegar software (system for management of research papers), software for Farzan research assistants (system for management of research commissions) and Faramak (system for SMS distribution).

Farasa, one of the most important products of the institute in the field of IT, encompasses over 200 educational courses with more than 15,000 users so far. The courses deal with research and technology skills, entrepreneurship, and governmental clerk educations.
The electronic newsletter of Farzan for research and technology is another product in the field of information technology. The institute has received confirmation letters from the computer guild, high council of informatics, and center for development of information technology and digital media at the Ministry of Culture.

In this festival, the efforts of Dr. Gholamreza Habibi were acknowledged with a medal of supporting national product.

In addition to Farzan Institute, the festival appreciated with institutes including Mahan institute for higher education, Iranian industry and mining bank, Iranmehr manufacturing-mining group, Tak Parsian pioneer industries, Nargostar chemical industries, Chandlamsi corporation for development of communications, Sapna Co., Sepad Khorasan manufacturing and service complex, among others.

Alongside the conference, the Iranian national broadcasting corporation conducted an interview with the CEO of the institute and the representative of entrepreneurs in the high council of employment on the occasion of his receiving the medal of supporting national product.

National Corporations Festival

Dr. Gholamreza Habibi, top national entrepreneur and CEO of Farzan Institute for Advancement of Science, Research and Technology, was acknowledged as the top manager in the National Corporations Festival and received a certificate of honors and the conference’s statuette.

The conference was held on October 5, 2012 in the Conference Hall of Islamic Republic of Iran Broadcasting. The conference abstract booklet offered a report of Farzan Institute’s activities.

The report mentions 30 international contracts and agreements signed by the institutes, publication of 390 articles in international journals, selection of Farzan Institute as top entrepreneur of Tehran province as well as the national competitions in 2011, and receiving the innovation award at the national convention of innovation pioneers in 2012. It has also been mentioned that the institute’s publications in the field of scientometry enjoy international appreciation.

In addition, Dr. Gholamreza Habibi, founder and CEO of the institute, was introduced and acknowledged. Furthermore, his executive and scientific resume (including his awards as author, researcher, and youth) was punctuated and his speech, as the top national entrepreneur, in the present of the Supreme Leader and Iranian economical activists was mentioned.

In this conference, in addition to Farzan Institute, other organizations including Post Bank Iran, Housing Corporation of Medical Council Members, Social Security Organization, and Corporation of Educational Services for Employees of the Evaluation Organization, were acknowledged.
Alongside the conference, channels of the Iranian national broadcasting company conducted televised interviews with Dr. Gholamreza Habibi as CEO of the institute and representative of entrepreneurs in the High Council of Employment.

News: Hemayat Daily interviews Dr. Gholamreza Habibi, the top Iranian entrepreneur and CEO of Farzan Clinical Research

Hemayat Daily introduced Dr. Gholamreza Habibi, the top Iranian entrepreneur and CEO of Farzan Clinical Research in an elaborate interview. The interview presents him as an innovative physician, the founder of the first Iranian clinical research organization, and entrepreneurship analyst.

The headline in Hemayat Daily reads, “Clinical Research Organization: the Missing Link of Pharmaceutical Industries in iran” above a comprehensive report of the CEO of Farzan Clinical Research.

Excerpts from the report read, “He is also the founder of Farzan Clinical Research Institute– the first Iranian organization to deal with clinical research as confirmed by the Food and Drug Administration (Iranian FDA) - Ministry of Health. He has established the first Iranian scientific writing center which has prepared over 370 papers published in prestigious international journals. In addition, he is the founder and the first supervisor of the Office for Compilation and Revision of Medical Textbooks at Tehran University of Medical Sciences”.

In this interview, Dr. Habibi punctuated the need for supporting small and medium enterprises (SMEs), particularly knowledge-based institutes.

News: The number of articles published by Farzan in prestigious international journals exceeded 400.

The number of articles published in affiliation with Farzan Institute for Clinical Research in prestigious international journals exceeded 400. In September 2012, Farzan managed to have 12 articles accepted for publication in prestigious international journals. Two articles have been published in journals with double-digit impact factors in this year alone. It must be noted that as the pioneer of the scientific writing service provider in Iran, Farzan has successfully published over 400 papers in prestigious international journals with a maximum impact factor of 24, and thus contributed to the advancement of science production in Iran without any dependence on governmental resources.

The scientific writing team of Farzan Clinical Research is ready to offer research service and consultations to all universities, research centers, research-based organizations, faculty members and researchers of Iran.

Farzan Clinical Research manages a phase III B RCT in Iran for Merck Serono

According to the contract between Farzan Clinical Research and Clintec International, Farzan Clinical Research would manage the Iranian sites for a study on infertility sponsored by Merck Serono. This is a phase IIIB interventional multicenter and multinational study. Royan Institute, one of the most famous research centers in Iran, would recruit the patients. Iranian Ministry of Health and Medical Education - FDA has also approved the study. FDA National Ethics Committee and Royan Institutional Ethics Committee have also approved the study.

Farzan Clinical Research is the first Iranian Clinical Research Organization (CRO). Farzan Clinical Research is now an important partner for many Universities, research centers, scientific societies as well as pharmaceutical and medical device industry. After 10 years experience in providing medical research services as Farzan Institute for Science, Research & Technology, Farzan Clinical Research was founded in Feb 2008 as the first Iranian registered CRO and now offers Clinical Trial Management, Clinical Trial Monitoring, Data Management, Biostatistics and Medical Writing services. Farzan Clinical Research is certified by Ministry of Health and Medical Education- Food and Drug Organization (FDA) - Islamic Republic of Iran. The Best National Entrepreneur prize was awarded to Farzan Clinical Research and Farzan was acknowledged by President of Islamic Republic of Iran in July 2011.

Clintec International is a privately owned medium sized CRO with a global reach and a strong presence in the emerging markets of Asia Pacific, Middle East & Africa and Eastern & Central Europe. With flexible resourcing services across 80 countries, ClinTec provides clinical research personnel and support services to the pharmaceutical, biotechnology and medical device industry.

Merck Serono is a pharmaceutical company headquartered in Geneva, Switzerland. In addition to internal research and development activities Merck Serono is also involved in publicly funded collaborative research projects, with other industrial and academic partners. Merck Serono is the Largest division of Merck KgaA, Established in January 5, 2007 as a Biopharmaceutical company. The number of Employees is about 17000 and the Total revenue of Merck Serono was € 5.9 billion in 2011. The major therapeutic areas are Oncology, Neurodegenerative Diseases, Fertility, Endocrinology, CardioMetabolic Care & General Medicine. The products of Merck Serono is commercialized in 150 countries.

News: Dr. Gholamreza Habibi, CEO of Farzan Institute, in live television program of News Channel

Dr. Gholamreza Habibi, CEO of Farzan Clinical Research Institute and top national entrepreneur, attended the live morning news feed of the National News Channel at 7:00 a.m. on Sunday, July 29 to present the achievements of Farzan Institute for Advancement of Science, Research and Technology, discuss the issue of entrepreneurship in Iran, and answer the questions of the callers.

Dr. Habibi referred to the achievements of Farzan Institute and stated, “The institute has founded the first scientific writing center in Iran, and has so far managed to publish over 390 articles in prestigious international journals”. He also mentioned the establishment of the first Iranian clinical research organization (CRO) and added, “This organization is responsible for pharmaceutical research projects and has exported specialized services worldwide through more than 30 contracts and agreements on an international level. Also, the organization supports the ideas of Iranian researchers in the field of pharmaceutical research”.

The CEO of Farzan Institute stated, “The institute supports the knowledge-based entrepreneurs in pharmaceutical fields and is ready to share its experiences with those eager to trod on this path”.

Another Success: Dr. Gholamreza Habibi, CEO of Farzan Institute, was acknowledged at the National Festival of Innovation Pioneers

The products and services provided by Dr. Gholamreza Habibi, CEO of Farzan Institute for Science, Research and Technology, were appreciated at the National Festival of Innovation Pioneers with a statuette of innovation. The festival was held on July 7 in the Conventions Hall of the National Radio and Television Organization.
It is noteworthy that ever since its establishment, Farzan Institute has consistently prioritized innovations in its activities.

The institute founded the first Iranian Clinical Research Organization, approved by the Ministry of Health and Medical Education, Food and Drug Administration (FDA).

Farzan Clinical Research provides scientific writing service to Novo Nordisk, a Danish Pharmaceutical company.

Farzan Clinical Research and Novo Nordisk signed a contract. According to this contract, Farzan Clinical Research provides medical and scientific writing services to Novonordisk. The major topic is about Diabetes Type II.

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 34,700 employees in 75 countries, and markets its products in 180 countries.

Farzan Clinical Research is the first Iranian Clinical Research Organization (CRO). Farzan Clinical Research is now an important partner for many Universities, research centers, scientific societies as well as pharmaceutical and medical device industry. After 10 years experience in providing medical research services as Farzan Institute for Science, Research & Technology, Farzan Clinical Research was founded in Feb 2008 as the first Iranian registered CRO and now offers Clinical Trial Management, Clinical Trial Monitoring, Data Management, Biostatistics and Medical Writing services. Farzan Clinical Research is certified by Ministry of Health and Medical Education- Food and Drug Organization (FDA) - Islamic Republic of Iran. The Best National Entrepreneur prize was awarded to Farzan Clinical Research and Farzan was acknowledged by President of Islamic Republic of Iran in July 2011.

“How I Succeeded” Conference in the university of economical studies

Dr. Gholamreza Habibi, CEO of Farzan Institute for Advancement of Science, Research and Technology and top national entrepreneur was invited by the university of economical studies to deliver a speech on entrepreneurship in the conference of “How I succeeded”. The conference also acknowledged his achievements in the field of entrepreneurship.

The second conference of “How I succeeded” was held in the Payambar Azam hall of the university of economical studies on February 20, 2012 with participations from top entrepreneurs and experts as well as a large number of university professors and students.
In this conference, in addition to Dr. Habibi, CEO of Farzan Institute, the other speakers included Ms. Moghimi chairwoman of the Chamber of Commerce and CEO and founder of Sadid Bar International Transportation Corporation, Mr. Hadavi, CEO of Kohan Charm Co., and authorities of the university of economical studies to deliver speeches on success.

At the end of the ceremonies, Dr. Habibi was acknowledged for his success in entrepreneurship with a certificate of honors and special gifts.

Alongside the conference, the TV program Tolu’ conducted an interview with Dr. Gholamreza Habibi and he made comments on knowledge-based entrepreneurship.

Membership in Hi-Tech Service Center of Pardis Technology Park

The membership of Farzan Institute in the Hi-Tech Service Center of Pardis Technology Park enables it to not only provide research service, but also offer hi-tech technological services to Iranian researchers and knowledge-based corporations via the chain of idea-to-market in order to commercialize knowledge-based products.

The Hi-tech Service Center of Pardis Technology Park aims to support knowledge-based corporations. As investing in knowledge-based corporations entails high risk and long return periods, it is crucial to support these corporations. It is especially important in Iran, where these corporations will play a pivotal role in fulfillment of the charter of the 20-year perspective for a knowledge-based economy.

In line with the objective of the center, Farzan Institute for Advancement of Science, Research and Technology is prepared to provide its services in different domains of technology development and the chain of idea-to-market for knowledge-based corporations. In addition, Iranian scientists and researchers may contact the institute in order to convert their valuable ideas to commercial products.

A branch of Farzan Institute opened in Pardis Technology Park

Farzan Institute for Advancement of Sciences, Research and Technology gained membership of Pardis Science and Technology Park in October 2011. Farzan’s membership was confirmed after visits and review of the documents provided.

Pardis Technology Park is located 20 Km northeast of Tehran and constitutes the “technology heaven of the region”. It is under authority of the republic’s president and the board of directors includes 14 individuals from ministries, scientific and academic centers presided by the first vice president.

Membership in the park requires an educated research team (with 70% of personnel holding at least a bachelor’s degree) as well as involvement in research activities, advancement of borders of human knowledge, commercialization of research results, organization of technical knowledge, and provision of research and educational services with high added value. Farzan Institute provided its full documentation to the Park and was granted membership after comprehensive reviews made by Park authorities.
According to the Charter of Perspective of Iran’s Development in 20 Years, the nation’s economy will be knowledge-based by the year 2026. This requires for knowledge-based products and industry which in turn depend on development and growth of knowledge-based corporations.

As understood from the international experience, science and technology parks form the key foundation for development of knowledge-based corporations. Farzan Institute, as the top knowledge-based entrepreneur sought membership in the park for the purpose of extending its activities and finding its way to international markets.

It must be noted that Pardis Park has certain relative and legal advantages over other research parks and centers of the region and is thus more likely to become a large zone for economical and scientific activities. It enjoys the necessary ties for connecting to actual and potential markets worldwide and thus broadening the international markets of Iran.

Dr. Habibi, CEO of Farzan institute, delivers speech in the presence of the Supreme Leader and economical activists of Iran

Dr. Gholamreza Habibi, CEO of Farzan Institute for Science, Research and Technology and top Iranian entrepreneur in 2011, was invited to the Supreme Leader’s meeting with select economical activists and he delivered a speech on science-based entrepreneurship.

The CEO of the institute presented an analysis of the challenges faced by entrepreneurship in Iran, and provided information on the field of science-based entrepreneurship. His speech was especially noted by the Supreme Leader.

Top Iranian Entrepreneur

Another Success: Dr. Gholamreza Habibi, CEO of Farzan Institute for Advancement of Science, Research and Technology, was selected the Top Iranian Entrepreneur in 2011.

Farzan Institute for Science, Research and Technology was selected as the top entrepreneur in the service sector in the Sixth National Festival for Appreciating Top Entrepreneurs in 2011. Dr. Gholamreza Habibi, the founder and CEO of the institute, was thereby awarded a certificate of honor and the festival’s statuette by President of Islamic Republic of Iran.

The festival was held on July 25 in Shahid Beheshti Conference Hall at the president’s residence. The President, the Minister of Labor and Social Affairs, some members of parliament and other authorities attended the ceremonies.

In the beginning of the festival, some verses of the Holy Quran were recited, and then Dr. Habibi, as representative of top entrepreneurs, expressed his opinion about entrepreneurship and the challenges faced by entrepreneurs.

He highlighted the essentiality of presence on an international scale and exporting goods and services abroad, particularly knowledge-based goods and services, citing the example of FaraData software by Farzan Clinical Research. He stated that development of this software not only preserved monetary funds inside the country, but also created job opportunities for many Iranian experts. He opined that such an approach and accumulative saving of dollars will preserve billions of dollars inside the country.

The top Iranian entrepreneur concluded his speech thus, “Presence of a dynamic relation between universities and knowledge-based corporations may play a pivotal role in development of knowledge-based economics. The science and technology transferred from universities to knowledge-based corporations will contribute greatly to their formation and development”. He insisted that it is not sufficient to allocate resources to knowledge-based corporations; rather, it is crucial that students and graduates modify their attitude and try to create jobs rather than seeking them, and this should be accomplished by education, consultations and preparing the cultural background so that the small and medium knowledge-based enterprises may thrive.

Subsequently, Dr. Sheykholeslami, Minister of Labor and Social Affairs, made his speech. He mentioned that the number of constructive projects in different parts of Iran is rising by day, and that the entire nation are determined to take up the steps of development and bring about the progress of the country.

The ceremony continued with Dr. Ahmadinejad’s speech. He cited parts of Dr. Habibi’s speech and emphasized the need for an economical revolution and amendments in the labor law.

It is noteworthy that the participants in the national festival were first assessed in provincial festivals for entrepreneurs in industry, agriculture and service sectors, and the top entrepreneurs in each province were then judged for participation in the national festival. After being selected and appreciated as the top entrepreneur in the service sector of Tehran province, Farzan Institute was also chosen as the Top National Entrepreneur and received honors in the presence of the President of the Islamic Republic of Iran.

The National Festival for Appreciation of Top Entrepreneurs was concluded with the award of certificates and statuettes by the Minister of Labor, the Minister’s Vice President and some other high ranking authorities.

Farzan: Top Knowledge-Based Entrepreneur in 2011

Farzan Institute for Advancement of Science, Research and Technology was selected as the top entrepreneur in the Sixth National Festival for Appreciating Top Entrepreneurs in 2011 and received the festivals certificate of honor and statuette.

The Sixth National Festival for Appreciating Top Entrepreneurs was held on July 25 by the Bureau of Labor and Social Affairs of Tehran province. Out of 18 entrepreneurs who found their way into the finals, 10 were selected as top entrepreneurs of the province. In this year, 250 applicants had registered for the competitions, and 18 individuals were selected for the finals.

Dr. Gholamreza Habibi, founder and CEO of the institute, was selected the Top Entrepreneur and awarded a certificate of honor and a statuette.

The ceremonies were attended by Mr. Doostali, vice president to the minister of labor and social affairs, Mr. Tamaddon, governor of Tehran, Mr. Torki, governor’s deputy for planning and policy making, Mr. Bashiri, representative of Pakdasht at the parliament, Mr. Kalatehahi, directing manager of Tehran’s association of corporations, and some other officials of Tehran province.

Alongside the ceremonies, an exposition of the achievements of entrepreneurs of Tehran was held. The stand of Farzan Institute introduced and presented the achievements of 10 years of its history and the innovations it has pioneered. The stand was visited and appreciated by high-ranking officials of the nation, including vice-president to the minister of labor and social affairs, members of parliament, directing manager of the bureau of labor and social affairs of Tehran province, and officials of Tehran’s governorship.

Farzan Institute, as a knowledge-based institute and the first Iranian organization for clinical research, has always placed innovations on top its priorities.

A number of priorities undertaken by Farzan Institute, is presented below:

• Farzan: The first Iranian organization for clinical research;
• Farzan: The first specialized center for scientific writing in Iran;
• Farzan: The first Iranian organization for information management;
• Farasaye Pazhuhesh: The first package of electronic training for research skills;
• FaraData: The first online system of management of clinical data;
• Faranegar: The first online system of management of research articles;
• The first package of electronic training for knowledge-based entrepreneurship;
• The first Iranian network for research education (RTNet);
• The first online database of surgical neurologic diseases (SNR);
• Publishing the first electronic newsletter of Iranian research

During the festival, the national news agency and News Channel conducted interviews with Dr. Habibi, the CEO of Farzan Institute. In addition, daily journals of Donayaye Eghtesad, Jahane Eghtesad, and Tehran Times covered the event and reported the achievements of Farzan Institute.

Faradata: System for online management of clinical information

In order to provide data management services, Farzan Institute has developed and provided the system for management of clinical information – Faradata. The online electronic system started functioning in 2009 and currently hosts numerous research projects. Faradata constitutes the first system of electronic and online management of clinical data with web-based software for electronic data capture (EDC) and information management in epidemiologic and clinical studies. It has been technically approved by the Iranian high council of informatics and holds the certificate of software patent from the information technology center at Ministry of Culture.

The software of Faradate is designed for bilingual use in English and Persian. One of the most important features of Faradata is its web-based nature with a special design to support patient documentation in different conditions and with a flexible and modifiable structure.

Faradata is designed with international standards with a high capability for data sharing, enabling data sharing among different centers as well as data publication on regional and national levels. The modular and highly flexible structure is an important feature of the software, as it makes it possible to modify the structure of databases and electronic questionnaires easily and rapidly based on the needs of each center or geographical region.

Faradata also provides the ability for users to change the appearance of the software to match it with their desire.

Farzan Clinical Research Provides Statistical Analysis Service to Roche Pharma Company

Farzan Clinical Research Provides Statistical Analysis and Protocol writing Services to Iranian Branch of Roche Pharmaceutica Company – Akbarieh Company. The main fields of the studies are Gastric Cancer and Lung Cancer.

Farzan Clinical Research is the first Iranian Clinical Research Organization (CRO). Farzan Clinical Research is now an important partner for many Universities, research centers, scientific societies as well as pharmaceutical and medical device industry. After 10 years experience in providing medical research services as Farzan Institute for Science, Research & Technology, Farzan Clinical Research was founded in Feb 2008 as the first Iranian registered CRO and now offers Clinical Trial Management, Clinical Trial Monitoring, Data Management, Biostatistics and Medical Writing services. Farzan Clinical Research is certified by Ministry of Health and Medical Education- Food and Drug Organization (FDA) - Islamic Republic of Iran. The Best National Entrepreneur prize was awarded to Farzan Clinical Research and Farzan was acknowledged by President of Islamic Republic of Iran in July 2011.

Akbarieh was established in 1890 to supply pharmaceuticals and fine chemicals to Iran, operated by the Akbarieh family ever since. Akbarieh has the expertise to work with and represent multinational companies in Iran, promoting their products and technology, importing, warehousing, sales and services of their products in our market. Our customers are the medical community, health professionals, and manufacturers of pharmaceuticals, food, cosmetic and feed industries.

Roche is a leading research-based healthcare company with combined strengths in pharmaceuticals and diagnostics. As the world’s biggest biotech company it develops truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics which already today are involved in up to 70% of therapy decisions. Roche’s broad diagnostic and bioanalytical tools not only enable innovations in science but also offer full breadth of technologies to develop new testing methods as well as companion diagnostics for Personalised Healthcare. Personalised Healthcare aims at providing the right medicine to the right patient at the right time to improve health, quality of life and survival time of patients.

Farzan Clinical Research and Sanofi-Aventis will launch OPTIC registry in Iran.

Farzan Clinical Research and Sanofi-Aventis will launch OPTIC registry in Iran. They have signed a contract and will soon begin the registry in 5 major Iranian hospitals.

The Outcomes in Patients with TIA and Cerebrovascular disease (OPTIC) registry with the registration number of CLOPI_R_01789, recruits patients for secondary prevention of stroke.

Five clinical sites are located in Tehran and Mashhad, including Hazrat-e-Rasul Hospital, Sina Hospital, Shariati Hospital, Loghman Hospital and Firuzgar Hospital. Patients would be followed for a period of 2 years.

Sanofi is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur). With more than 110,000 employees in a hundred countries, Sanofi has a strong presence worldwide.

Farzan Clinical Research is the first Iranian Contract Research Organization (CRO). Farzan Clinical Research is now an important partner for many Universities, research centers, scientific societies as well as pharmaceutical and medical device industry. After 10 years experience in providing medical research services as Farzan Science, Research & Technology Institute , Farzan Clinical Research was founded in Feb 2008 as the first Iranian registered CRO and now offering Clinical Trial Management, Clinical Trial Monitoring, Data Management, Biostatistics and Medical Writing services. Our focus is on innovative solutions that reduce cost and time for our customers.

Farzan Clinical Research is certified by Ministry of Health and Medical Education- Food and Drug Organization (FDA) - Islamic Republic of Iran.

ISMAR in Iran by Farzan Clinical Research: a new cooperation between Sanofi-Aventis and Farzan Clinical Research

Farzan Clinical Research and Sanofi-Aventis signed a contract to run a new survey on Allergic Rhinitis in Iran.

Farzan Clinical Research will launch "ISMAR -International Survey on the Management of Allergic Rhinitis by Physicians and Patients" in Iran, sponsored by Sanofi-Aventis pharmaceutical company. ISMAR with the registration number of : DIREG_R_02676, is an international, multicenter, non–interventional cross-sectional study focused on management of Allergic Rhinitis. Farzan Clinical Research manages this study in Iran in 27 clinical sites.

Sanofi-Aventis is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. With more than 110,000 employees in a hundred countries, Sanofi-Aventis has a strong presence worldwide.

Farzan Clinical Research is the first Iranian Clinical Research Organization (CRO). Farzan Clinical Research is now an important partner for many Universities, research centers, scientific societies as well as pharmaceutical and medical device industry. After 10 years experience in providing medical research services as Farzan Institute for Science, Research & Technology, Farzan Clinical Research was founded in Feb 2008 as the first Iranian registered CRO and now offers Clinical Trial Management, Clinical Trial Monitoring, Data Management, Biostatistics and Medical Writing services. Farzan Clinical Research is certified by Ministry of Health and Medical Education- Food and Drug Organization (FDA) - Islamic Republic of Iran.

Farzan Clinical Research monitors BRIDGE Screening Programme in Iran, sponsored by Sanofi-Aventis

"Bridge Screening Programme of Frequency of Bipolar Disorders in Patients with a Major Depressive Episode with or without Certain Psychiatric Comorbid Conditions" with registration number of DIREG_R_3653, is the new field of cooperation between Sanofi-Aventis and Farzan Clinical Research. Farzan will monitor the study in a number of Iranian clinical sites.

This study is aimed to provide an estimate of the frequency of bipolar disorders in patients with the diagnosis of major depressive episode and to identify the relation between bipolar disorder and some other comorbid conditions.

Sanofi-Aventis is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. With more than 110,000 employees in a hundred countries, Sanofi-Aventis has a strong presence worldwide.

Farzan Clinical Research is the first Iranian Clinical Research Organization (CRO). Farzan Clinical Research is now an important partner for many Universities, research centers, scientific societies as well as pharmaceutical and medical device industry. After 10 years experience in providing medical research services as Farzan Institute for Science, Research & Technology, Farzan Clinical Research was founded in Feb 2008 as the first Iranian registered CRO and now offers Clinical Trial Management, Clinical Trial Monitoring, Data Management, Biostatistics and Medical Writing services. Farzan Clinical Research is certified by Ministry of Health and Medical Education- Food and Drug Organization (FDA) - Islamic Republic of Iran.

Farzan Clinical Research monitors Oncology Clinical Trials sponsored by Sanofi-Aventis in Iran.

According to a new contract between Sanofi-Aventis and Farzan Clinical Research, Farzan will monitor Oncology Clinical Trials sponsored by Sanofi.

Sanofi-Aventis is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. With more than 110,000 employees in a hundred countries, Sanofi-Aventis has a strong presence worldwide.

Farzan Clinical Research is the first Iranian Clinical Research Organization (CRO). Farzan Clinical Research is now an important partner for many Universities, research centers, scientific societies as well as pharmaceutical and medical device industry. After 10 years experience in providing medical research services as Farzan Institute for Science, Research & Technology, Farzan Clinical Research was founded in Feb 2008 as the first Iranian registered CRO and now offers Clinical Trial Management, Clinical Trial Monitoring, Data Management, Biostatistics and Medical Writing services. Farzan Clinical Research is certified by Ministry of Health and Medical Education- Food and Drug Organization (FDA) - Islamic Republic of Iran.

ACCESS registry in Iran: Sanofi-Aventis and Farzan Clinical Research

Farzan Clinical Research is now in cooperation with Sanofi-Aventis for Monitoring ACCESS registry in two major Iranian Heart Centers, including Tehran Heart Center and Shahid Rajai Heart Hospital.

"ACCESS – Acute Coronary Events: A Multinational survey of current management strategies" with registration number of DIREG_R_01959, is sponsored by Sanofi-Aventis Paris – France to evaluate risk stratification, current management and one year outcomes in patients with unstable angina. This study has a baseline event, studying hospitalization and discharge of the patients and two follow-ups. It is conducted in 20 developing countries.

In this study, 700 patients in the best and most famous Iranian Heart Hospitals would be recruited.

Sanofi-Aventis is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. With more than 110,000 employees in a hundred countries, Sanofi-Aventis has a strong presence worldwide.

Farzan Clinical Research is the first Iranian Clinical Research Organization (CRO). Farzan Clinical Research is now an important partner for many Universities, research centers, scientific societies as well as pharmaceutical and medical device industry. Farzan Clinical Research was founded in Feb 2008 as the first Iranian registered CRO and now offers Clinical Trial Management, Clinical Trial Monitoring, Data Management, Biostatistics and Medical Writing services. Farzan Clinical Research is certified by Ministry of Health and Medical Education- Food and Drug Organization (FDA) - Islamic Republic of Iran.

Please login or register to add comments